It’s tempting to be back at prices seen before pilot programs or b2b revenue. sold some at 29 cents some months ago bought more today at 12 cents. The conviction of management to partner with world leading hospitals and develop a valid SaaS solution makes this a rare bird on the asx imo. A large HMD holding is a small cost for most investors. good luck LTH
